World’s largest hair drug testing company & scientific leader launches new screening tests for Oxymorphone and D-Amphetamine/Adderall®. ACTON, Mass., June 2, 2015 /PRNewswire/ — Psychemedics Corporation PMD, -0.06% hair testing pioneer and global leader for over twenty-five years, announced the addition of 2 new drugs to the company’s drug testing panels. In response to growing … Read more
DECLARES 74th CONSECUTIVE QUARTERLY DIVIDEND Acton, Massachusetts, February 10, 2015 — Psychemedics Corporation (NASDAQ: PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2014. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of February 23, 2015, to be paid on … Read more
DECLARES 67th CONSECUTIVE QUARTERLY DIVIDEND ACTON, Mass., May 7, 2013 /PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced first quarter financial results for the period ended March 31, 2013. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of May 17, 2013 to be paid on May … Read more